309 related articles for article (PubMed ID: 25758750)
21. Syntheses and preliminary evaluation of [(18) F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma.
Li Y; Zhang D; Shi Y; Guo Z; Wu X; Ren JL; Zhang X; Wu H
Contrast Media Mol Imaging; 2016 Jul; 11(4):262-71. PubMed ID: 26931574
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and evaluation of
Li J; Peng J; Tang W; Rawson J; Karunananthan J; Jung M; Ma Y; Shively JE; Kandeel F
Bioorg Chem; 2020 May; 98():103718. PubMed ID: 32171991
[TBL] [Abstract][Full Text] [Related]
23. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
[TBL] [Abstract][Full Text] [Related]
24. In vivo imaging of transplanted islets with 64Cu-DO3A-VS-Cys40-Exendin-4 by targeting GLP-1 receptor.
Wu Z; Todorov I; Li L; Bading JR; Li Z; Nair I; Ishiyama K; Colcher D; Conti PE; Fraser SE; Shively JE; Kandeel F
Bioconjug Chem; 2011 Aug; 22(8):1587-94. PubMed ID: 21692471
[TBL] [Abstract][Full Text] [Related]
25. Distinctive detection of insulinoma using [
Murakami T; Fujimoto H; Hamamatsu K; Yamauchi Y; Kodama Y; Fujita N; Fujikura J; Shimizu Y; Nakamoto Y; Kimura H; Saji H; Inagaki N
Sci Rep; 2021 Jul; 11(1):15014. PubMed ID: 34294854
[TBL] [Abstract][Full Text] [Related]
26. Preliminary evaluation of GLP-1R PET in the diagnosis and risk stratification of pheochromocytomas.
Li M; Liu Y; Xu Y; Li Y; Pan D; Wang L; Yan J; Wang X; Yang R; Yang M
Neoplasma; 2020 Jan; 67(1):27-36. PubMed ID: 31686522
[TBL] [Abstract][Full Text] [Related]
27. Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas.
Yue X; Kiesewetter DO; Guo J; Sun Z; Zhang X; Zhu L; Niu G; Ma Y; Lang L; Chen X
Bioconjug Chem; 2013 Jul; 24(7):1191-200. PubMed ID: 23750453
[TBL] [Abstract][Full Text] [Related]
28. Pilot study of a novel (18)F-labeled FSHR probe for tumor imaging.
Xu Y; Pan D; Zhu C; Xu Q; Wang L; Chen F; Yang R; Luo S; Yang M; Yan Y
Mol Imaging Biol; 2014 Aug; 16(4):578-85. PubMed ID: 24389931
[TBL] [Abstract][Full Text] [Related]
29. PET of glucagonlike peptide receptor upregulation after myocardial ischemia or reperfusion injury.
Gao H; Kiesewetter DO; Zhang X; Huang X; Guo N; Lang L; Hida N; Wang H; Wang H; Cao F; Niu G; Chen X
J Nucl Med; 2012 Dec; 53(12):1960-8. PubMed ID: 23139087
[TBL] [Abstract][Full Text] [Related]
30. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
[TBL] [Abstract][Full Text] [Related]
32. Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
Wild D; Antwi K; Fani M; Christ ER
J Nucl Med; 2021 Jul; 62(Suppl 2):44S-50S. PubMed ID: 34230073
[TBL] [Abstract][Full Text] [Related]
33. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.
Gao H; Lang L; Guo N; Cao F; Quan Q; Hu S; Kiesewetter DO; Niu G; Chen X
Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):683-92. PubMed ID: 22274731
[TBL] [Abstract][Full Text] [Related]
34. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
[TBL] [Abstract][Full Text] [Related]
35. Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging.
Liu Q; Pan D; Cheng C; Zhang D; Zhang A; Wang L; Jiang H; Wang T; Liu H; Xu Y; Yang R; Chen F; Yang M; Zuo C
PLoS One; 2015; 10(11):e0141668. PubMed ID: 26540114
[TBL] [Abstract][Full Text] [Related]
36. Preliminary biological evaluation of
Lu C; Jiang Q; Hu M; Tan C; Yu H; Hua Z
Oncotarget; 2017 Aug; 8(31):51086-51095. PubMed ID: 28881632
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of A Novel GLP-1R Ligand for PET Imaging of Prostate Cancer.
Yue Y; Xu Y; Huang L; Pan D; Bai Z; Wang L; Yang R; Yan J; Song H; Li X; Yang M
Anticancer Agents Med Chem; 2019; 19(4):509-514. PubMed ID: 30068284
[TBL] [Abstract][Full Text] [Related]
38. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
[TBL] [Abstract][Full Text] [Related]
39. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
40. Three methods for 18F labeling of the HER2-binding affibody molecule Z(HER2:2891) including preclinical assessment.
Glaser M; Iveson P; Hoppmann S; Indrevoll B; Wilson A; Arukwe J; Danikas A; Bhalla R; Hiscock D
J Nucl Med; 2013 Nov; 54(11):1981-8. PubMed ID: 24115530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
